Version October 2024
| Patients who are medically fit and eligible for cisplatin-based therapy meet all of the criteria below: |
| ECOG performance status <2 or a Karnofsky performance status >70% |
| Creatinine clearance ≥60 mL/min |
| No significant hearing loss (measured at audiometry of 25 dB at 2 contiguous frequencies) |
| Grade <2 peripheral neuropathy (ie, sensory alteration or paresthesia, including tingling, but not interfering with activities of daily living) |
| No clinical evidence of NYHA class III or greater heart failure |
Do you want to add Medilib to your home screen?
